The hierarchical progression of tau tangles in Alzheimer’s disease—from the entorhinal cortex to the neighboring hippocampus and out into the great neocortical beyond—is emblazoned in the minds of AD ...

In addition, they support the utility of tau PET imaging as a biomarker to identify persons at high risk for development of clinical AD symptoms, to track disease progression, and to monitor ...

A team from the University of Geneva (UNIGE) and the Geneva University Hospitals (HUG) has demonstrated that tau PET - a novel imaging technique for visualising the tau protein - can predict ...

A team from the University of Geneva (UNIGE) and the Geneva University Hospitals (HUG) has demonstrated that tau PET - a novel imaging technique for visualizing the tau protein - can predict ...

Piramal Imaging and AC Immune present first clinical data for tau PET-imaging tracer PI-2620 at the International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological ...

By quantifying the amount of tau in the brain tissue with PET imaging, physicians can appropriately stage Alzheimer's disease in patients and determine the best treatment options. "Identifying tau ...

[18F]PI-2620 is a next-generation, F18-labeled PET imaging agent currently in Phase 3 clinical development for detecting tau pathology in Alzheimer's disease. The compound is also being ...

Furthermore, compared to traditional biomarkers such as amyloid β and phosphorylated tau levels, the use of advanced imaging techniques such as PET scans has also provided more accurate insights ...

Tau imaging with 18F-Flortaucipir PET in Alzheimer’s disease. The figure shows a prototypical tau accumulation pattern, obtained by comparing tau load of patients with Alzheimer’s disease vs ...

A team from the University of Geneva (UNIGE) and the Geneva University Hospitals (HUG) has demonstrated that tau PET -- a novel imaging technique for visualising the tau protein -- can predict ...